Financials
- Market Capitalization 202.53 M
- Employee 29
- Founded 2014
- CEO N/A
- Website www.cuebiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00FVMPFN7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.21
売上高対価格比率
3.17
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3596 | IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +27.43% | +7.21% | 208.99 M USD | ||
| 3610 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.53 USD | -3.07% | +6.75% | +6.30% | -13.36% | 203.85 M USD | ||
| 3623 | ACOG Alpha Cognition Inc. - Common Stock | 9.16 USD | -5.95% | -5.76% | +11.57% | +9.96% | 199.49 M USD | ||
| 3625 | NKTX Nkarta, Inc. - Common Stock | 2.76 USD | +0.36% | +5.34% | +31.43% | +28.37% | 197.68 M USD |